The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis

Wing Yan Chiu, Joanne; Fong Tang, Yuen; Yao, Tzy‐Jyun; Wong, Ashley; Wong, Hilda; Leung, Roland; Chan, Pierre; To Cheung, Tan; Chan, Albert; Pang, Roberta; Fan, Sheung‐Tat; T.P. Poon, Ronnie; Yau, Thomas

doi:10.1002/cncr.27543

Public

The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis

Published in Cancer • Apr 19, 2012

Authors:

Joanne Wing Yan Chiu

Yuen Fong Tang

Tzy‐Jyun Yao

Abstract

BACKGROUND: This study explored the efficacy, tolerability, and survival benefits of using sorafenib in patients with Child-Pugh class B (CPB) cirrhosis. METHODS: Patients with advanced hepatocellular carcinoma who were treated with sorafenib at Queen Mary Hospital, Hong Kong, China, were analyzed r...

Subject

Medicine

Hepatocellular carcinoma

Sorafenib

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!